Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Malinovschi (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), C. Janson (Uppsala, Sweden), H. Hedenström (Uppsala, Sweden), K. Bröms (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), M. Högman (Uppsala, Sweden). Additive information from mMRC and CCQ in relation to COPD exacerbations. 2395

Member's Comments

No comment yet.

Related content which might interest you: Additive information from mMRC and CAT in relation to exacerbations in a Swedish COPD cohort Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019 Minimal clinically important difference and predictive validity of the mMRC and mBorg in acute exacerbations of COPD Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease Year: 2017 Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007 Change in breathlessness and symptom scores during hospitalisation with exacerbations of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 511s Year: 2004 Detecting exacerbations using the clinical COPD questionnaire Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 Scales of assesment in COPD. Correlation with clinical and functional parameters Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 CCQ and ACQ scores in obstructive lung disease: one questionnaire for all? Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Correlation between COPD assessment test (CAT) and mMRC dyspnea scale in evaluationg COPD symptoms Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 Impact of halotherapy on COPD exacerbations Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Evaluation of COPD exacerbations using the EXACT-U Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Impact of severity on three spirometric definitions of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002 Impact of lung function impairment and exacerbation history on COPD patient-reported utility Source: International Congress 2014 – COPD markers Year: 2014 Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT Source: International Congress 2014 – Markers Year: 2014 CAT’ or ’mMRC’ – Which is a better symptom scale in recent GOLD COPD classification? Source: International Congress 2015 – COPD: interesting notes Year: 2015 Breathlessness perception in COPD: Relationship with exacerbation frequency Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015